Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pituitary
Published in: Pituitary 1/2002

01-01-2002

Expression of Aromatase P450 is Increased in Spontaneous Prolactinomas of Aged Rats

Authors: José Carretero, Deborah Jane Burks, Gabriel Vázquez, Manuel Rubio, Elena Hernández, Pilar Bodego, Ricardo Vázquez

Published in: Pituitary | Issue 1/2002

Login to get access
Metadata
Title
Expression of Aromatase P450 is Increased in Spontaneous Prolactinomas of Aged Rats
Authors
José Carretero
Deborah Jane Burks
Gabriel Vázquez
Manuel Rubio
Elena Hernández
Pilar Bodego
Ricardo Vázquez
Publication date
01-01-2002
Publisher
Kluwer Academic Publishers
Published in
Pituitary / Issue 1/2002
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1023/A:1022176631922

Other articles of this Issue 1/2002

Pituitary 1/2002 Go to the issue

OriginalPaper

Oncological Complications of Excess GH in Acromegaly

OriginalPaper

Self Image and Quality of Life in Acromegaly

OriginalPaper

Therapy of Diabetes and Dyslipidemia in Acromegaly

OriginalPaper

Isolated Familial Somatotropinomas: Clinical Features and Analysis of the MEN1 Gene

OriginalPaper

A Relapsing Remitting Lymphocytic Hypophysitis

OriginalPaper

Hypothalamic-Pituitary Sarcoidosis with Hypopituitarism. Long-Term Remission with Methylprednisolone Pulse Therapy
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits